Vanguard Group
ATXI

Vanguard Group’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-46,293
Closed -$6.83K 4449
2024
Q1
$6.83K Hold
46,293
﹤0.01% 4437
2023
Q4
$7.45K Hold
46,293
﹤0.01% 4485
2023
Q3
$32.7K Buy
+46,293
New +$32.7K ﹤0.01% 4457
2022
Q3
Sell
-131,569
Closed -$36K 4612
2022
Q2
$36K Sell
131,569
-321,084
-71% -$87.9K ﹤0.01% 4599
2022
Q1
$218K Hold
452,653
﹤0.01% 4524
2021
Q4
$411K Hold
452,653
﹤0.01% 4463
2021
Q3
$675K Buy
452,653
+2,671
+0.6% +$3.98K ﹤0.01% 4329
2021
Q2
$1.13M Sell
449,982
-248,151
-36% -$623K ﹤0.01% 4125
2021
Q1
$4.24M Sell
698,133
-241,573
-26% -$1.47M ﹤0.01% 3615
2020
Q4
$5.59M Buy
939,706
+295,502
+46% +$1.76M ﹤0.01% 3312
2020
Q3
$6.98M Buy
644,204
+215,625
+50% +$2.34M ﹤0.01% 2979
2020
Q2
$4.62M Buy
428,579
+121,036
+39% +$1.3M ﹤0.01% 3133
2020
Q1
$2.75M Buy
307,543
+139,390
+83% +$1.25M ﹤0.01% 3212
2019
Q4
$1.61M Buy
168,153
+30,769
+22% +$295K ﹤0.01% 3507
2019
Q3
$819K Buy
137,384
+38,171
+38% +$228K ﹤0.01% 3700
2019
Q2
$625K Hold
99,213
﹤0.01% 3789
2019
Q1
$471K Buy
99,213
+29,052
+41% +$138K ﹤0.01% 3786
2018
Q4
$379K Sell
70,161
-28,180
-29% -$152K ﹤0.01% 3790
2018
Q3
$279K Sell
98,341
-300
-0.3% -$851 ﹤0.01% 3954
2018
Q2
$353K Buy
98,641
+3,915
+4% +$14K ﹤0.01% 3889
2018
Q1
$427K Buy
94,726
+50,534
+114% +$228K ﹤0.01% 3815
2017
Q4
$161K Buy
44,192
+19,652
+80% +$71.6K ﹤0.01% 3958
2017
Q3
$136K Buy
+24,540
New +$136K ﹤0.01% 3965